China Long-Acting Bronchodilator Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2025
China long-acting bronchodilator market is anticipated to grow at a substantial rate of 3.8% during the forecast period. High level of air pollution and the significant number of smokers in China is boosting the demand for long-acting bronchodilators in the country. Additionally, the rising geriatric population susceptible to asthma and COPD within the country is also driving the demand for bronchodilators. From June 2012 to May 2015, a survey was conducted by the Ministry of Health and Ministry of Science and Technology of China. About 51,000 citizens participated in the survey with 21,500 men and 29,500 women, according to which, it was estimated that about 100 million adults in 2015 had the problem of COPD in the country. The prevalence is higher in men as compared to women. As per the estimation, there were 68.4 million men and 31.5 million women affected by COPD.
To Request a Sample of our Report on Peptide
and Anticoagulant Drug Market: https://www.omrglobal.com/request-sample/china-long-acting-bronchodilator-market
China long-acting bronchodilator
market is segmented on the basis of route of administration, application, and
end-user. Based on the route of administration, the market is classified into
oral, nasal, parenteral, and inhalation. Moreover, on the basis of application,
the market has been classified into asthma and COPD diseases. The asthma disease
application segment dominated the regional market in 2018 and is further
estimated to follow the same trend over the forecast period. This is mainly due
to the increasing pool of aging population susceptible to the high prevalence
of asthma in the country.
(Get 15% Discount on Buying this Report)
A
full Report of China Long-Acting Bronchodilator Market is Available @ https://www.omrglobal.com/industry-reports/china-long-acting-bronchodilator-market
China Long-Acting Bronchodilator Market Segmentation
By Route of Administration
·
Oral
·
Nasal
·
Parenteral
·
Inhalation
By Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Company Profiles
·
Adamis Pharmaceuticals Corp.
·
AstraZeneca PLC
·
Boehringer Ingelheim International GmbH
·
GlaxoSmithKline PLC
·
Novartis AG
·
ResMed Corp.
·
Pulmatrix Inc.
·
Savara, Inc.
·
Sunovion Pharmaceuticals
·
Teva Pharmaceuticals Industries Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment